Third Harmonic Bio Inc [NASDAQ: THRD] closed the trading session at $3.25.
The stocks have a year to date performance of -68.42 percent and weekly performance of -33.67 percent. The stock has been moved at -73.18 percent over the last six months. The stock has performed -61.08 percent around the most recent 30 days and changed -76.67 percent over the most recent 3-months.
If compared to the average trading volume of 245.40K shares, THRD reached to a volume of 14185378 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Third Harmonic Bio Inc [THRD]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for THRD shares is $17.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on THRD stock is a recommendation set at 1.60. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Raymond James have made an estimate for Third Harmonic Bio Inc shares, keeping their opinion on the stock as Mkt Perform, with their previous recommendation back on February 11, 2025. While these analysts kept the previous recommendation, Morgan Stanley raised their target price from $12 to $20. The new note on the price target was released on August 09, 2024, representing the official price target for Third Harmonic Bio Inc stock. Previously, the target price had yet another raise to $23, while Stifel analysts kept a Buy rating on THRD stock.
The Average True Range (ATR) for Third Harmonic Bio Inc is set at 0.64 The Price to Book ratio for the last quarter was 0.49, with the Price to Cash per share for the same quarter was set at 6.57.
THRD stock trade performance evaluation
Third Harmonic Bio Inc [THRD] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -33.67. With this latest performance, THRD shares dropped by -61.08% in over the last four-week period, additionally sinking by -73.18% over the last 6 months – not to mention a drop of -63.97% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for THRD stock in for the last two-week period is set at 18.64, with the RSI for the last a single of trading hit 15.36, and the three-weeks RSI is set at 22.60 for Third Harmonic Bio Inc [THRD]. The present Moving Average for the last 50 days of trading for this stock 8.72, while it was recorded at 4.50 for the last single week of trading, and 11.74 for the last 200 days.
Third Harmonic Bio Inc [THRD]: An insightful look at the core fundamentals
Third Harmonic Bio Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 42.50 and a Current Ratio set at 42.50.
Third Harmonic Bio Inc [THRD]: Institutional Ownership
There are presently around $93.98%, or 103.33%% of THRD stock, in the hands of institutional investors. The top three institutional holders of THRD stocks are: ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC with ownership of 10.91 million shares, which is approximately 26.8961%. ORBIMED ADVISORS LLC, holding 5.78 million shares of the stock with an approximate value of $$75.13 million in THRD stocks shares; and ORBIMED ADVISORS LLC, currently with $$56.76 million in THRD stock with ownership which is approximately 10.7653%.
